Share your feedback: revision of good pharmacogenomic guidance

The concept paper proposing updates to the guideline on good pharmacogenomic practice is open for public consultation until 31 March 2026. The planned revisions reflect advances in genomics and include updates to methodology, interpretation of genomic results, reporting standards and study design. Stakeholders are encouraged to share their views via the EU Survey.